Literature DB >> 20069294

Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy.

Stefan A J Timmer1, Tjeerd Germans, Marco J W Götte, Iris K Rüssel, Pieter A Dijkmans, Mark Lubberink, Jurrien M ten Berg, Folkert J ten Cate, Adriaan A Lammertsma, Paul Knaapen, Albert C van Rossum.   

Abstract

PURPOSE: Next to hypertrophy, hypertrophic cardiomyopathy (HCM) is characterized by alterations in myocardial energetics. A small number of studies have shown that myocardial external efficiency (MEE), defined by external work (EW) in relation to myocardial oxidative metabolism (MVO(2)), is reduced. The present study was conducted to identify determinants of MEE in patients with HCM by use of dynamic positron emission tomography (PET) and cardiovascular magnetic resonance imaging (CMR).
METHODS: Twenty patients with HCM (12 men, mean age: 55.2 + or - 13.9 years) and 11 healthy controls (7 men, mean age: 48.1 + or - 10 years) were studied with [(11)C]acetate PET to assess MVO(2). CMR was performed to determine left ventricular (LV) volumes and mass (LVM). Univariate and multivariate analyses were employed to determine independent predictors of myocardial efficiency.
RESULTS: Between study groups, MVO(2) (controls: 0.12 + or - 0.04 ml x min(-1) x g(-1), HCM: 0.13 + or - 0.05 ml x min(-1) x g(-1), p = 0.64) and EW (controls: 9,139 + or - 2,484 mmHg x ml, HCM: 9,368 + or - 2,907 mmHg x ml, p = 0.83) were comparable, whereas LVM was significantly higher (controls: 99 + or - 21 g, HCM: 200 + or - 76 g, p < 0.001) and MEE was decreased in HCM patients (controls: 35 + or - 8%, HCM: 21 + or - 10%, p < 0.001). MEE was related to stroke volume (SV), LV outflow tract gradient, NH(2)-terminal pro-brain natriuretic peptide (NT-proBNP) and serum free fatty acid levels (all p < 0.05). Multivariate analysis revealed that SV (ss = 0.74, p < 0.001) and LVM (ss = -0.43, p = 0.013) were independently related to MEE.
CONCLUSION: HCM is characterized by unaltered MVO(2), impaired EW generation per gram of myocardial tissue and subsequent deteriorated myocardial efficiency. Mechanical external efficiency could independently be predicted by SV and LVM.

Entities:  

Mesh:

Year:  2010        PMID: 20069294     DOI: 10.1007/s00259-009-1350-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  43 in total

1.  Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy.

Authors:  H Laine; C Katoh; M Luotolahti; H Yki-Järvinen; I Kantola; A Jula; T O Takala; U Ruotsalainen; H Iida; M Haaparanta; P Nuutila; J Knuuti
Journal:  Circulation       Date:  1999-12-14       Impact factor: 29.690

Review 2.  Myocardial energetics and efficiency: current status of the noninvasive approach.

Authors:  Paul Knaapen; Tjeerd Germans; Juhani Knuuti; Walter J Paulus; Pieter A Dijkmans; Cornelis P Allaart; Adriaan A Lammertsma; Frans C Visser
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

3.  Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation.

Authors:  R Krams; M J Kofflard; D J Duncker; C Von Birgelen; S Carlier; M Kliffen; F J ten Cate; P W Serruys
Journal:  Circulation       Date:  1998-01-27       Impact factor: 29.690

4.  Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy.

Authors:  L Sieverding; W I Jung; J Breuer; S Widmaier; A Staubert; F van Erckelens; O Schmidt; M Bunse; T Hoess; O Lutz; G J Dietze; J Apitz
Journal:  Am J Cardiol       Date:  1997-08-04       Impact factor: 2.778

5.  Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study.

Authors:  Paul Knaapen; Marco J W Götte; Walter J Paulus; Jaco J M Zwanenburg; Pieter A Dijkmans; Ronald Boellaard; J Tim Marcus; Jos W R Twisk; Cees A Visser; Albert C van Rossum; Adriaan A Lammertsma; Frans C Visser
Journal:  Radiology       Date:  2006-08       Impact factor: 11.105

6.  31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging.

Authors:  H Sakuma; K Takeda; T Tagami; T Nakagawa; S Okamoto; T Konishi; T Nakano
Journal:  Am Heart J       Date:  1993-05       Impact factor: 4.749

7.  Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.

Authors:  Helena Tuunanen; Johanna Kuusisto; Jyri Toikka; Pertti Jääskeläinen; Päivi Marjamäki; Keijo Peuhkurinen; Tapio Viljanen; Petri Sipola; Kira Q Stolen; Jarna Hannukainen; Pirjo Nuutila; Markku Laakso; Juhani Knuuti
Journal:  J Nucl Cardiol       Date:  2007-05-10       Impact factor: 5.952

8.  Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops.

Authors:  Emanuele Meliga; Paul Steendijk; Marco Valgimigli; Folkert J Ten Cate; Patrick W Serruys
Journal:  Am J Cardiol       Date:  2008-03-04       Impact factor: 2.778

9.  Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy.

Authors:  Paul Knaapen; Ronald Boellaard; Marco J W Götte; Pieter A Dijkmans; Linda M C van Campen; Carel C de Cock; Gert Luurtsema; Cees A Visser; Adriaan A Lammertsma; Frans C Visser
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

10.  Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

Authors:  Jenifer G Crilley; Ernest A Boehm; Edward Blair; Bheeshma Rajagopalan; Andrew M Blamire; Peter Styles; William J McKenna; Ingegerd Ostman-Smith; Kieran Clarke; Hugh Watkins
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

View more
  13 in total

1.  Evaluation of ECG-gated [(11)C]acetate PET for measuring left ventricular volumes, mass, and myocardial external efficiency.

Authors:  Nils Henrik Hansson; Lars Tolbod; Hendrik Johannes Harms; Henrik Wiggers; Won Yong Kim; Esben Hansen; Tomas Zaremba; Jørgen Frøkiær; Steen Jakobsen; Jens Sørensen
Journal:  J Nucl Cardiol       Date:  2016-04-19       Impact factor: 5.952

Review 2.  Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Julian O M Ormerod; Michael P Frenneaux; Mark V Sherrid
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

3.  Repeatable and reproducible measurements of myocardial oxidative metabolism, blood flow and external efficiency using 11C-acetate PET.

Authors:  Kai Yi Wu; Vincent Dinculescu; Jennifer M Renaud; Shin-Yee Chen; Ian G Burwash; Lisa M Mielniczuk; Rob S B Beanlands; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2018-02-16       Impact factor: 5.952

4.  Cardiac myosin binding protein C insufficiency leads to early onset of mechanical dysfunction.

Authors:  Candida L Desjardins; Yong Chen; Arthur T Coulton; Brian D Hoit; Xin Yu; Julian E Stelzer
Journal:  Circ Cardiovasc Imaging       Date:  2011-12-07       Impact factor: 7.792

5.  Pharmacokinetics, metabolism, biodistribution, radiation dosimetry, and toxicology of (18)F-fluoroacetate ((18)F-FACE) in non-human primates.

Authors:  Ryuichi Nishii; William Tong; Richard Wendt; Suren Soghomonyan; Uday Mukhopadhyay; Julius Balatoni; Osama Mawlawi; Luc Bidaut; Peggy Tinkey; Agatha Borne; Mian Alauddin; Carlos Gonzalez-Lepera; Bijun Yang; Juri G Gelovani
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

6.  The value of myocardial work in assessment of ventricular function in patients with non-obstructive hypertrophic cardiomyopathy.

Authors:  Chenguang Yang; Ying Guo; Xiang Wang; Ruisheng Zhang; Fang Wang; Huolan Zhu
Journal:  BMC Cardiovasc Disord       Date:  2022-07-05       Impact factor: 2.174

Review 7.  Methods for measuring right ventricular function and hemodynamic coupling with the pulmonary vasculature.

Authors:  Alessandro Bellofiore; Naomi C Chesler
Journal:  Ann Biomed Eng       Date:  2013-02-20       Impact factor: 3.934

8.  Myocardial Oxygen Consumption and Efficiency in Aortic Valve Stenosis Patients With and Without Heart Failure.

Authors:  Nils Henrik Stubkjær Hansson; Jens Sörensen; Hendrik Johannes Harms; Won Yong Kim; Roni Nielsen; Lars P Tolbod; Jørgen Frøkiær; Kirsten Bouchelouche; Karen Kaae Dodt; Inger Sihm; Steen Hvitfeldt Poulsen; Henrik Wiggers
Journal:  J Am Heart Assoc       Date:  2017-02-06       Impact factor: 5.501

9.  Cardiac work is related to creatine kinase energy supply in human heart failure: a cardiovascular magnetic resonance spectroscopy study.

Authors:  Refaat E Gabr; AbdEl-Monem M El-Sharkawy; Michael Schär; Gurusher S Panjrath; Gary Gerstenblith; Robert G Weiss; Paul A Bottomley
Journal:  J Cardiovasc Magn Reson       Date:  2018-12-10       Impact factor: 5.364

10.  Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications.

Authors:  Betty Raman; Rina Ariga; Marco Spartera; Sanjay Sivalokanathan; Kenneth Chan; Sairia Dass; Steffen E Petersen; Matthew J Daniels; Jane Francis; Robert Smillie; Adam J Lewandowski; Eric O Ohuma; Christopher Rodgers; Christopher M Kramer; Masliza Mahmod; Hugh Watkins; Stefan Neubauer
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-02-01       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.